Key result
Electrical heterogeneities in IHD drive dynamic remodeling, increasing arrhythmic risk and compromising cardiac mechanics.
Why the study?
Cardiac diseases perturb baseline electrical properties of cardiac tissue, increasing arrhythmic risk, while biological variability produces wide-ranging clinical symptoms that complicate diagnosis and treatment.
This review highlights the critical role of electrical heterogeneities in ischemic heart disease, detailing how electrophysiological and structural remodeling influences arrhythmic risk and cardiac function.
A healthy heart shows intrinsic electrical heterogeneities that play a significant role in cardiac activation and repolarization. However, cardiac diseases may perturb the baseline electrical properties of the healthy cardiac tissue, leading to increased arrhythmic risk and compromised cardiac functions. Moreover, biological variability among patients produces a wide range of clinical symptoms, which complicates the treatment and diagnosis of cardiac diseases. Ischemic heart disease is usually caused by a partial or complete blockage of a coronary artery. The onset of the disease begins with myocardial ischemia, which can develop into myocardial infarction if it persists for an extended period. The progressive regional tissue remodeling leads to increased electrical heterogeneities, with adverse consequences on arrhythmic risk, cardiac mechanics, and mortality. This review aims to summarize the key role of electrical heterogeneities in the heart on cardiac function and diseases. Ischemic heart disease has been chosen as an example to show how adverse electrical remodeling at different stages may lead to variable manifestations in patients. For this, we have reviewed the dynamic electrophysiological and structural remodeling from the onset of acute myocardial ischemia and reperfusion to acute and chronic stages post-myocardial infarction. The arrhythmic mechanisms, patient phenotypes, risk stratification at different stages, and patient management strategies are also discussed. Finally, we provide a brief review on how computational approaches incorporate human electrophysiological heterogeneity to facilitate basic and translational research.
No takes yet. Share an insight, caveat, or question.
Martinez‐Navarro et al. (2024) conducted a review in Ischemic heart disease. Electrical heterogeneities in ischemic heart disease drive dynamic electrophysiological and structural remodeling, increasing arrhythmic risk and compromising cardiac mechanics across disease stages.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: